Elsevier

Pathology

Volume 23, Issue 3, 1991, Pages 185-188
Pathology

Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney

https://doi.org/10.3109/00313029109063563Get rights and content

Summary

HMB-45 (melanocytic cell-specific monoclonal antibody) immunoreactivity was investigated in 10 cases of angiomyo-lipoma (AML) (1 with massive regional lymph node involvement) of the kidney and detected in all of them. No HMB-45 immunoreactivity was found in other tumors of the region which can occasionally be confused with AML, such as renal cell carcinoma, Wilms’ tumor, and retroperitoneal sarcoma (leiomyosarcoma and liposarcoma). These findings indicate that HMB-45 is not a melanocyte-restricted marker and suggest that its expression might be useful in distinguishing AML from other tumors of the kidney and retroperitoneum.

References (17)

There are more references available in the full text version of this article.

Cited by (0)

View full text